Flolan (2015-03-20)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| N440 | - Recalling Firm
- GlaxoSmithKline Inc.
- 7333 Mississauga Road
- Mississauga
- L5N 6L4
- Ontario
- CANADA
- Marketing Authorization Holder
- GlaxoSmithKline Inc.
- 7333 Mississauga Road
- Mississauga
- L5N 6L4
- Ontario
- CANADA
| Flolan | Powder for solution | DIN 02230848 | Epoprostenol (Epoprostenol Sodium) 1.5 mg/vial |
An out-of-specification result for known impurity during stability study.